On February 19, 2026 Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, reported participation at the following investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

36th Annual Oppenheimer Life Sciences Healthcare Conference
Format: Virtual fireside chat and one-on-one investor meetings
Presentation Date/Time: Thursday, February 26, 2026 at 12:00pm ET
Location: Virtual

46th Annual TD Cowen Healthcare Conference
Format: Hybrid presentation & fireside chat and one-on-one investor meetings
Presentation Date/Time: Wednesday, March 4th, 2026 at 11:50am ET
Location: Boston, MA

Leerink Global Healthcare Conference
Format: One-on-one investor meetings
Date: March 8-11, 2026
Location: Miami, FL

2026 Jefferies Biotech on the Beach Summit
Format: One-on-one investor meetings
Date: March 9-11, 2026
Location: Miami, FL

Barclays 28th Annual Global Healthcare Conference
Format: One-on-one investor meetings
Date: March 10-12, 2026
Location: Miami, FL

A live webcast of the presentations can be accessed by visiting the "For Investors" page on the Tyra Biosciences website and will be available for replay following the event.

(Press release, Tyra Biosciences, FEB 19, 2026, View Source [SID1234662802])